Bio-Techne
TECH
#1831
Rank
$11.34 B
Marketcap
$72.37
Share price
-0.01%
Change (1 day)
38.56%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): $1.17

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $1.17. In 2025 the company made an earnings per share (EPS) of $0.52 a decrease over its 2024 EPS that were of $1.00.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$1.17125%
2025$0.52-48%
2024$1.00-29.58%
2023$1.42-14.97%
2022$1.6724.16%
2021$1.3417.98%
2020$1.14-10.94%
2019$1.28101.57%
2018$0.64-16.99%
2017$0.7645.02%
2016$0.53-20.97%
2015$0.67-14.97%
2014$0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
$18.62 1,491.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$3.60 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$8.56 631.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
$5.65 382.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$1.98 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-$0.21-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
$8.33 611.97%๐Ÿ‡บ๐Ÿ‡ธ USA